Selected Publications

A full list of Jennifer Donegan’s publications can be found here.


Knockdown of Lhx6 during embryonic development results in neurophysiological alterations and behavioral deficits analogous to schizophrenia in adult rats.
Elam, H.B., Perez, S.M., Donegan, J.J., Eassa, N.E., Lodge, D.J. Schizophrenia Research, 2024, 267:113-121.


Discrete hippocampal projections are differentially regulated by parvalbumin and somatostatin interneurons.
Lodge, D.J., Elam, H.B., Boley, A.M., Donegan, J.J. Nature Communications, 2023, 14(1):6653.


Developmental alterations in the transcriptome of three distinct rodent models of schizophrenia.
Donegan, J.J., Boley, A.M., Carless, M.A., Lodge, D.J. PLoS One, 2020, 15(6):e0232200.


Stem cells for improving the treatment of neurodevelopmental disorders.
Donegan, J.J. and Lodge, D.J. Stem Cells in Development, 2020, 29(17):1118.


Modulation of extrasynaptic GABA A alpha 5 receptors in the ventral hippocampus normalizes physiological and behavioral deficits in a circuit specific manner.
Donegan, J.J., Boley, A.M., Yamaguchi, Y., Toney, G.M., and Lodge, D.J. Nature Communications, 2019, 10(1): 2819.


Embryonic stem cell transplants as a therapeutic strategy in a rodent model of autism.
Donegan, J.J., Boley, A.M., and Lodge, D.J. Neuropsychopharmacology, 2018, 43(8): 1789-1798.


Cell-based therapies for the treatment of schizophrenia.
Donegan, J.J. and Lodge, D.J. Brain Research, 2017, 1655: 262-269.


Stem cell derived interneuron transplants as a treatment for schizophrenia: preclinical validation in a rodent model.
Donegan, J.J., Tyson, J.A., Branch, S. Y., Beckstead, M.J., Anderson, S. A., Lodge, D.J. Molecular Psychiatry, 2017, 22 (10): 1492-1501.